Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Hematology journal rankings 2014
69 ranked journals · Subfield in Medicine
Hematology has 69 ranked journals in 2014. The median journal has an OJR of 0.72, below the world average of 1.00, up 0.01 on 2013; Q1 starts at OJR 1.14. The top three are Blood, Blood Reviews, and Leukemia.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Hematology69
Show all 42 subfields
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
69 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1BloodElsevier BV · United States | 3.07Q1 | 8.90 0.11 down from 2013 | 4,801 | 14% | $5,500 | ||
2Blood ReviewsElsevier BV · United Kingdom | 2.95Q1 | 8.34 1.34 up from 2013 | 95 | 32% | $5,220 | ||
3LeukemiaSpringer Nature · United Kingdom | 2.47Q1 | 7.17 0.25 up from 2013 | 1,142 | 51% | $5,190 | ||
4HematologyAmerican Society of Hematology · United States | 2.32Q1 | 5.16 0.79 down from 2013 | 291 | 38% | — | ||
5Transfusion Medicine ReviewsElsevier BV · United States | 1.93Q1 | 3.46 1.59 down from 2013 | 93 | 5% | $3,970 | ||
6Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 1.88Q1 | 4.74 0.36 up from 2013 | 1,149 | 96% | $3,750 | ||
7Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.82Q1 | 4.77 0.58 down from 2013 | 208 | 33% | — | ||
8HaematologicaOAFerrata Storti Foundation · Italy | 1.78Q1 | 5.01 0.14 up from 2013 | 1,018 | 100% | $2,157 | ||
9British Journal of HaematologyWiley · United Kingdom | 1.68Q1 | 4.54 0.16 up from 2013 | 1,286 | 56% | $5,190 | ||
10Seminars in HematologyElsevier BV · United States | 1.48Q1 | 3.58 0.32 down from 2013 | 141 | 9% | $4,070 | ||
11Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 1.47Q1 | 3.37 0.42 down from 2013 | 148 | 12% | $3,730 | ||
12American Journal of HematologyWiley · United States | 1.38Q1 | 4.16 0.38 up from 2013 | 797 | 71% | $5,450 | ||
13Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.32Q1 | 3.72 0.04 up from 2013 | 761 | 100% | $3,650 | ||
14Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.28Q1 | 4.01 0.45 up from 2013 | 376 | 36% | — | ||
15Blood Cancer JournalOASpringer Nature · United Kingdom | 1.23Q1 | 3.52 0.28 up from 2013 | 168 | 100% | $5,290 | ||
16Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.21Q1 | 3.39 0.02 down from 2013 | 108 | 29% | $3,790 | ||
17TransfusionWiley · United States | 1.14Q1 | 3.11 0.03 down from 2013 | 1,302 | 27% | $4,100 | ||
18Vox SanguinisWiley · United Kingdom | 1.14Q1 | 2.64 0.20 down from 2013 | 274 | 13% | $4,150 | ||
19Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.10Q2 | 2.96 0.30 up from 2013 | 740 | 26% | $4,990 | ||
20Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 1.10Q2 | 2.44 0.25 down from 2013 | 170 | 88% | $1,670 | ||
21Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.05Q2 | 3.63 2.56 up from 2013 | 87 | 100% | $2,650 | ||
22Expert Review of HematologyTaylor & Francis · United Kingdom | 0.97Q2 | 2.48 0.11 up from 2013 | 210 | 30% | — | ||
23Experimental HematologyElsevier BV · United States | 0.94Q2 | 2.56 0.29 down from 2013 | 316 | 100% | $3,250 | ||
24European Journal Of HaematologyWiley · United Kingdom | 0.92Q2 | 2.42 0.19 down from 2013 | 477 | 24% | $4,650 | ||
25Bone Marrow ResearchHindawi Publishing Corporation · United Kingdom | 0.90Q2 | 2.09 0.32 down from 2013 | 46 | 100% | — | ||
26Journal of Blood MedicineOADove Medical Press · New Zealand | 0.85Q2 | 2.25 0.22 up from 2013 | 54 | 100% | $2,320 | ||
27AnemiaOAHindawi Publishing Corporation · United Kingdom | 0.80Q2 | 2.28 0.30 up from 2013 | 67 | 100% | $1,100 | ||
28Annals of Laboratory MedicineOASeoul National University · South Korea | 0.79Q2 | 1.89 0.06 up from 2013 | 229 | 96% | — | ||
29Journal of Clinical ApheresisWiley · United States | 0.78Q2 | 2.37 0.10 down from 2013 | 155 | 7% | $3,920 | ||
30PlateletsOAInforma · United Kingdom | 0.77Q2 | 1.95 0.21 down from 2013 | 385 | 27% | $2,970 | ||
31Annals of HematologyOASpringer Science+Business Media · Germany | 0.77Q2 | 1.89 0.07 down from 2013 | 843 | 13% | $4,590 | ||
32International Journal of HematologySpringer Science+Business Media · Japan | 0.75Q2 | 2.15 0.07 down from 2013 | 690 | 21% | $4,390 | ||
33Leukemia ResearchElsevier BV · United Kingdom | 0.74Q2 | 2.27 0.24 up from 2013 | 967 | 13% | $3,910 | ||
34Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.73Q2 | 1.73 0.24 up from 2013 | 227 | 100% | $647 | ||
35Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.72Q2 | 1.92 0.14 down from 2013 | 1,628 | 22% | — | ||
36Leukemia Research and TreatmentHindawi Publishing Corporation · Egypt | 0.70Q3 | 2.29 0.81 up from 2013 | 35 | 100% | — | ||
37Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.70Q3 | 1.98 0.03 up from 2013 | 435 | 16% | $3,890 | ||
38Transfusion MedicineWiley · United Kingdom | 0.69Q3 | 1.59 0.01 down from 2013 | 207 | 13% | $3,700 | ||
39Blood Coagulation & FibrinolysisLippincott Williams & Wilkins · United Kingdom | 0.69Q3 | 1.68 0.02 up from 2013 | 500 | 8% | — | ||
40HaemophiliaWiley · United Kingdom | 0.68Q3 | 2.25 0.03 up from 2013 | 797 | 27% | $4,760 | ||
41International Journal of Laboratory HematologyWiley · United Kingdom | 0.65Q3 | 1.67 0.04 down from 2013 | 336 | 13% | $3,880 | ||
42Cytometry Part B Clinical CytometryWiley · United States | 0.60Q3 | 2.32 0.29 down from 2013 | 183 | 16% | $3,800 | ||
43Pediatric Hematology and OncologyTaylor & Francis · United Kingdom | 0.57Q3 | 1.39 0.13 up from 2013 | 315 | 5% | — | ||
44HämostaseologieThieme Medical Publishers (Germany) · Germany | 0.57Q3 | 1.47 0.07 down from 2013 | 174 | 0% | — | ||
45HematologyOAManey Publishing · United Kingdom | 0.54Q3 | 1.36 0.22 down from 2013 | 299 | 100% | $2,557 | ||
46Journal of Pediatric Hematology/OncologyLippincott Williams & Wilkins · United States | 0.54Q3 | 1.12 0.02 down from 2013 | 826 | 15% | — | ||
47Transfusion and Apheresis ScienceElsevier BV · United Kingdom | 0.51Q3 | 1.08 0.13 down from 2013 | 449 | 5% | $3,160 | ||
48The Korean Journal of HematologySouth Korea | 0.51Q3 | 1.31 0.41 up from 2013 | 127 | — | — | ||
49Blood ResearchOASouth Korea | 0.47Q3 | 1.00no 2013 value | 73 | 100% | $2,290 | ||
50Asian Journal of Transfusion ScienceOAMedknow · India | 0.47Q3 | 0.83 0.15 up from 2013 | 131 | 100% | — |
Subfields of Medicine, with Hematology highlighted.
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
20 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 69
- Window papers (baseline)
- 33,484 +2.9% from indicator year 2011
- Median OJR
- 0.7205 -1.2% from indicator year 2011
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.